Cure My Disease

Don't miss your cure!

 Log in / Sign up

New breathing monitor put to the test in healthy volunteers

NCT ID NCT06000852

Knowledge-focused Sponsor: Michael Chu Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new non-invasive breathing monitor in 27 healthy adults aged 22-99. The goal was to see if the new device measures breathing rate as accurately as the current standard method of manual counting. Participants wore both monitors while lying in different positions and breathing normally. The study did not involve any treatment or disease management.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

27 people

The number who actually took part.

Started

Aug 2022

Finished

Oct 2022

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 to 99 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Between age of 22-99 2. BMI between 15 and 35 kg/m\^2 Exclusion Criteria: 1. Medical history of serious cardiac or pulmonary diseases/conditions. 2. History of serious skin irritation caused by medical adhesives (tape). 3. Cannot lay still on your back for one (1) hour. 4. Pregnancy. 5. Unable to give written informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Respiratory monitoring are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Respiratory monitoring

More trials for these conditions

Other studies related to the condition(s) this trial covers.